Log in
Enquire now
T-Curx

T-Curx

Developer of T-cell-based personalized immunotherapy for cancer treatment

OverviewStructured DataIssuesContributors

Contents

t-curx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Regenerative medicine
Regenerative medicine
Cell therapy
Cell therapy
Biomedical engineering
Biomedical engineering
Location
Germany
Germany
CEO
‌
Ulf Grawunder
Founder
‌
Ulf Grawunder
‌
Michael Hudecek
Number of Employees (Ranges)
1 – 10
Email Address
info@t-curx.com
Investors
BioMedPartners
BioMedPartners
Highlight Capital
Highlight Capital
‌
i&i Biotech Fund
Bayern Kapital
Bayern Kapital
Founded Date
2017
Total Funding Amount (USD)
20,000,000
Latest Funding Round Date
December 17, 2025
Latest Funding Type
Series A
Series A
COO
‌
Marion Jung
Country
Germany
Germany
Headquarters
Bavaria
Bavaria

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
20,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like T-Curx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.